Actively Recruiting
Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
Led by Imperial College London · Updated on 2025-03-20
100
Participants Needed
3
Research Sites
73 weeks
Total Duration
On this page
Sponsors
I
Imperial College London
Lead Sponsor
M
Manchester University NHS Foundation Trust
Collaborating Sponsor
AI-Summary
What this Trial Is About
To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.
CONDITIONS
Official Title
Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older who can provide informed consent
- Diagnosis of chronic pulmonary aspergillosis
- Ability to speak and understand English
- Able to provide informed consent
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Ninewells Hospital & Medical School
Dundee, United Kingdom, DD1 9SY
Actively Recruiting
2
Imperial College London
London, United Kingdom
Actively Recruiting
3
Manchester NHS Foundation Trust
Manchester, United Kingdom
Actively Recruiting
Research Team
D
Dareen Marghlani, MSc
CONTACT
A
Anand Shah, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here